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Frontonasal encephalocoeleAbstract Paediatric patients undergoing radiological imaging often require sedation to minimise
motion artefacts. Sedation during Magnetic Resonance Imaging (MRI) poses many challenges to
the anaesthetist. Inadequate or failed sedation results in difﬁculty in keeping them motionless while
maintaining respiratory and hemodynamic stability. Secondly, limited access to the patient may
pose a safety risk during MRI. Dexmedetomidine, an a2-adrenoceptor agonist, has recently been
used as a sedative for diagnostic imaging studies. We report a use of dexmedetomidine for sedation
in MRI suite in a child with frontonasal encephalocoele. A two-year-old girl child weighing 11 kg
was scheduled for MRI of the brain and paranasal sinuses with nasal cavity under anaesthesia at
our institute. After applying standard monitoring, an initial loading dose of dexmedetomidine
was given @ 2 lg kg1 over 10 min followed by continuous infusion of dexmedetomi-
dine @ 1 lg kg1 h1. Sedation was monitored by the Ramsay Sedation Score (RSS), and as soon
as a score of 5 was achieved, the child was transferred to the MRI table. Anaesthetic conditions
were excellent, with minimal change in vital signs during the entire 35 min duration of the scan.
Imaging was successful with no motion artefacts.
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Paediatric patients undergoing radiological imaging often
require sedation to minimise motion artefacts. Sedation duringMagnetic Resonance Imaging (MRI) poses many challenges to
the anaesthetist. Inadequate or failed sedation results in difﬁ-
culty in keeping them motionless while maintaining respiratory
and hemodynamic stability. Secondly, limited access to the pa-
tient may pose a safety risk during MRI. Therefore, appropri-
ate drugs need to be selected, administered and titrated to
achieve these objectives [1]. Earlier, drugs like chloral hydrate,
pentobarbital, midazolam and propofol were used to provide
anaesthesia during such imaging studies in children, but the
incidence of complications and the need for securing airway
was high with the use of these drugs [2]. Dexmedetomidine,
an a2-adrenoceptor agonist, was introduced two decades ago
as a sedative and supplement to sedation in the intensive care
unit for patients whose trachea was intubated. However, since
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ative and hypnotic for patients undergoing procedures without
the need for tracheal intubation [3]. There are very few studies
about the use of this drug in paediatric population. We report
a use of dexmedetomidine for sedation in MRI suite in a child
with frontonasal encephalocoele.
2. Case report
A two-year-old girl child weighing 11 kg was scheduled for
MRI of the brain and paranasal sinuses with nasal cavity
under anaesthesia at our institute. Parents of the child gave a
history of some mass visible in the right nostril since birth
(Fig. 1). She had a complaint of snoring and mouth breathing
as a result of persistent nasal blockage. A computed tomogra-
phy (CT) scan was done at the age of one year which revealed a
large midline cribriform plate osseous defect with widened
foramen caecum-prenasal space-fontalis fonticulus, i.e. frontal
and nasal bones were found to be fused or were non-patent. A
ﬂuid ﬁlled pedunculated sac of attenuation value 0–5 HU
ﬁlling the right nasal cavity was seen in contiguous to right
basifrontal anterior cranial fossa giving an impression of sin-
cipital congenital nasofrontal encephalocoele. The child pre-
sented with high grade fever and neck rigidity about a
month back. She was diagnosed to be the case of pyogenic
meningitis for which she was hospitalised for a week and
recovered from the ailment. Paediatrician requested MRI of
the brain, paranasal sinuses and nasal cavity to evaluate the
extent of the mass in order to plan further management.
MRI was planned under anaesthesia or sedation. On pre-
anaesthetic examination, the child was conscious but irritable
and uncooperative. A diffuse swelling was present over the
nose and the frontal region. A polypoid solid mass was seen
in the right nasal cavity completely blocking it. The vital signs
were: Heart rate (HR) – 116/min; Blood pressure (BP) – 109/
38 mm Hg in the right brachial artery; Respiratory rate (RR)
– 25/min and Oxygen saturation (spO2) – 97% on room air.
On auscultation, the chest was clear on both sides without
any added sounds and the heart sounds were normal with no
evidence of murmur. On airway assessment, difﬁcult mask ven-
tilation was anticipated, as the base of nose was occupied by
the irregular shaped, uneven swelling. A difﬁcult airway cart
with oropharyngeal airways and i-gel of appropriate sizesFigure 1 Child showing nasal swelling and obstruction with
encephalocele.was prepared in case of any airway obstruction during the
imaging.
After conﬁrming nil per oral status of the child, an in-
formed written consent was taken from the parents of the child
for anaesthesia. EMLA was applied on the dorsum of the left
hand of the child. After 45 min, an intravenous line was se-
cured with a 24 gauge cannula. Standard monitoring was ap-
plied using electrocardiography, pulse-oximetry, manometry
and capnography. An initial loading dose of dexmedetomidine
was given @ 2 lg kg1 over 10 min followed by continuous
infusion of dexmedetomidine @ 1 lg kg1 h1 [4]. Sedation
was monitored by the Ramsay Sedation Score (RSS) and as
soon as a score of 5 was achieved, the child was transferred
to the MRI table. A RSS 4 or RSS 5 is a clinically derived scor-
ing system that is generally accepted as an adequate sedation
depth to tolerate diagnostic imaging studies.[5] Oxygen at
4 L min1 was administered via the paediatric face mask with
an end tidal CO2 sampling port afﬁxed to the mask. Soft foam
ear muffs were applied to the ears of the child to abate noise
from the MRI machine. A RSS of 5 was achieved in 6 min
and the procedure was started. The scan lasted for 35 min.
The imaging was successful with no motion artefacts. The
vitals were also stable throughout. There was a slight decrease
in HR till 99/min. There was no hypotension or decrease in
respiratory rate and oxygen saturation. The RSS remained be-
tween 5 and 6 throughout the study. Upon completion of the
study, drug infusion was stopped. The child was responding
to light tactile stimulation within 2 min. She was fully awake
and the vitals returned to baseline within 8 min. She was dis-
charged from the recovery room after 2 h and was observed
for another 24 h in the ward. No adverse event was noted.
3. Discussion
Frontonasal encephalocoeles are uncommon congenital mal-
formations, observed more commonly in south-east Asia. They
manifest as a clinically visible mass along the nose. The intra-
cranial root of most fronto-ethmoidal encephalocoeles lies at
the foramen caecum, a small ostium located at the bottom of
a small depression anterior to the crista galli and formed by
the closure of the frontal and ethmoid bones. MRI is the best
imaging modality for deﬁning the contents of an encephaloco-
ele prior to surgery. High-resolution CT may also be used to
display the bone anatomy, but the intracranial connection
and the extent of cerebral tissue in an encephalocoele are best
deﬁned with MR imaging which aids in prognosis and surgical
planning [6].
The usual technique for sedating paediatric patients in MRI
suite is general anaesthesia with controlled ventilation. Apart
from inherent anaesthetic implications of paediatric patients
and associated systemic abnormalities, difﬁculty in securing
the airway in this patient could have made induction of anaes-
thesia more challenging for the anaesthesiologists. The other
concern was to avoid compression of encephalocoele that
could have raised the intracranial pressure and even rupture
of associated frontal swelling leading to exposure of brain,
haemorrhage, CSF loss, meningitis, convulsions and death.
Thus, the need for a safer method of sedation with the avoid-
ance of airway manipulation was required [7].
Dexmedetomidine, an imidazole, is a potenta2-adrenoceptor
agonist that has eight times greater speciﬁcity for a2 receptors
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thought to be mediated through post-synaptic a2 receptors
which activate pertussis toxin-sensitiveGproteins; thus, increas-
ing conductance through potassium ion channels. Activation of
a2 receptors in the central nervous system, particularly in the
locus coeruleus, may cause a signiﬁcant reduction in central
sympathetic ﬂow and result in sedation and increased vagal
activity. Sedation with dexmedetomidine resembles light sleep.
Dexmedetomidine has been used solely to sedate children for
procedures without stimulation, and its use inMRI andCT scan
are becoming popular [8]. Dexmedetomidine is relatively unique
in its ability to provide sedation without causing respiratory
depression. In contrast to other hypnotics such as chloral
hydrate, pentobarbital, midazolam and propofol, sedation with
a2 agonists causes minimal respiratory depression [9]. Experi-
ence with the use of dexmedetomidine in paediatric patients
has been limited. By using dexmedetomidine, we were able to
maintain spontaneous ventilation during sedation in this child.
No respiratory depression was detected, consistent with what
has been observed with the use of dexmedetomidine in adults.
Oxygen saturation and the respiratory ratewerewellmaintained
throughout and a good quality MR image was obtained.
4. Conclusion
We conclude that dexmedetomidine when used in MRI suite
provides reliable and effective method of sedation in paediatric
subjects. Its use is associated with good success rate and
minimal side effects. It provides excellent anaesthetic condi-
tions without any alteration in respiratory and hemodynamic
status. However, more studies are required to establish the
role of this drug in the paediatric population.Conﬂicts of interest
None.
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